Docgo Inc Stock Performance
| DCGO Stock | USD 2.86 0.01 0.35% |
The firm shows a Beta (market volatility) of 0.74, which means possible diversification benefits within a given portfolio. As returns on the market increase, DocGo's returns are expected to increase less than the market. However, during the bear market, the loss of holding DocGo is expected to be smaller as well. At this point, DocGo Inc has a negative expected return of -0.58%. Please make sure to confirm DocGo's jensen alpha, accumulation distribution, relative strength index, as well as the relationship between the value at risk and day typical price , to decide if DocGo Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days DocGo Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (0.70) | Five Day Return (6.89) | Year To Date Return (33.80) | Ten Year Return (72.43) | All Time Return (72.43) |
1 | Disposition of 16500 shares by Leite Etalvina of DocGo at 4.34 subject to Rule 16b-3 | 12/17/2024 |
2 | Disposition of 18598 shares by Lee Bienstock of DocGo at 4.23 subject to Rule 16b-3 | 01/02/2025 |
3 | DocGo Stock Hits 52-Week High at 5.05 Amid Healthcare Demand - MSN | 02/04/2025 |
4 | Subdued Growth No Barrier To DocGo Inc. With Shares Advancing 33 | 02/11/2025 |
5 | DocGo Announces Upcoming Participation at TD Cowen 45th Annual Health Care Conference | 02/18/2025 |
6 | DocGo Inc Q4 2024 Earnings Report Preview What To Expect | 02/26/2025 |
7 | DocGo Announces Fourth Quarter and Full-Year 2024 Results | 02/27/2025 |
8 | DocGo Inc Q4 2024 Earnings Call Highlights Navigating Challenges and Seizing Growth ... | 02/28/2025 |
9 | All You Need to Know About Motion Acquisition Rating Upgrade to Buy | 03/03/2025 |
10 | Disposition of 59360 shares by Lee Bienstock of DocGo at 3.03 subject to Rule 16b-3 | 03/07/2025 |
11 | Disposition of 1500000 shares by Stanley Vashovsky of DocGo subject to Rule 16b-3 | 03/13/2025 |
| Begin Period Cash Flow | 72.2 M |
DocGo |
DocGo Relative Risk vs. Return Landscape
If you would invest 429.00 in DocGo Inc on December 18, 2024 and sell it today you would lose (143.00) from holding DocGo Inc or give up 33.33% of portfolio value over 90 days. DocGo Inc is currently does not generate positive expected returns and assumes 4.5145% risk (volatility on return distribution) over the 90 days horizon. In different words, 40% of stocks are less volatile than DocGo, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
DocGo Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DocGo's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as DocGo Inc, and traders can use it to determine the average amount a DocGo's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1283
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DCGO |
Estimated Market Risk
| 4.51 actual daily | 40 60% of assets are more volatile |
Expected Return
| -0.58 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average DocGo is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DocGo by adding DocGo to a well-diversified portfolio.
DocGo Fundamentals Growth
DocGo Stock prices reflect investors' perceptions of the future prospects and financial health of DocGo, and DocGo fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DocGo Stock performance.
| Return On Equity | 0.0431 | ||||
| Return On Asset | 0.0379 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 257.07 M | ||||
| Shares Outstanding | 101.98 M | ||||
| Price To Earning | 17.46 X | ||||
| Price To Book | 0.90 X | ||||
| Price To Sales | 0.47 X | ||||
| Revenue | 616.56 M | ||||
| Gross Profit | 213.57 M | ||||
| EBITDA | 41.7 T | ||||
| Net Income | 13.36 T | ||||
| Cash And Equivalents | 198.14 M | ||||
| Cash Per Share | 1.96 X | ||||
| Total Debt | 57.19 T | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 4.76 X | ||||
| Book Value Per Share | 3.15 X | ||||
| Cash Flow From Operations | 70.34 T | ||||
| Earnings Per Share | 0.18 X | ||||
| Market Capitalization | 291.67 M | ||||
| Total Asset | 455.62 T | ||||
| Retained Earnings | (1.4 T) | ||||
| Working Capital | 182.68 M | ||||
About DocGo Performance
By examining DocGo's fundamental ratios, stakeholders can obtain critical insights into DocGo's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that DocGo is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 5.15 | 5.41 | |
| Return On Capital Employed | 0.09 | 0.09 |
Things to note about DocGo Inc performance evaluation
Checking the ongoing alerts about DocGo for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DocGo Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DocGo Inc generated a negative expected return over the last 90 days | |
| DocGo Inc has high historical volatility and very poor performance | |
| Latest headline from MacroaxisInsider: Disposition of 1500000 shares by Stanley Vashovsky of DocGo subject to Rule 16b-3 |
- Analyzing DocGo's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DocGo's stock is overvalued or undervalued compared to its peers.
- Examining DocGo's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DocGo's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DocGo's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DocGo's stock. These opinions can provide insight into DocGo's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DocGo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DocGo. If investors know DocGo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DocGo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.09 | Earnings Share 0.18 | Revenue Per Share | Quarterly Revenue Growth (0.39) | Return On Assets |
The market value of DocGo Inc is measured differently than its book value, which is the value of DocGo that is recorded on the company's balance sheet. Investors also form their own opinion of DocGo's value that differs from its market value or its book value, called intrinsic value, which is DocGo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DocGo's market value can be influenced by many factors that don't directly affect DocGo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DocGo's value and its price as these two are different measures arrived at by different means. Investors typically determine if DocGo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DocGo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.